Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer
Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL
International Society of Paediatric Surgical Oncology (IPSO) surgical practice guidelines
Maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Eye metastasis in breast cancer: Case report and review of literature
Update on the new EUSOMA quality indicators for breast cancer
The optimal approach after neoadjuvant treatment: The Lucerne toolbox
Lung cancer in India
Tumour agnostic treatments in GI cancer
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO